<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Hansa Biopharma - Updated note from Intron Health Research]]></title><description><![CDATA[<p dir="auto">Vedhæftede analyse er sponsoret af Hansa Biopharma.</p>
<p dir="auto">Hansa Biopharma har en betalt digital IR-aftale med Proinvestor.</p>
<p dir="auto"><a href="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/111167_20230306_HNSA___Intron_Health_Building_A_Foundation_for_Growth__11_pgs_.pdf" rel="nofollow ugc">111167_20230306_HNSA___Intron_Health_Building_A_Foundation_for_Growth__11_pgs_.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/444820/hansa-biopharma-updated-note-from-intron-health-research</link><generator>RSS for Node</generator><lastBuildDate>Sat, 27 Jun 2026 11:09:56 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/444820.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 08 Mar 2023 13:55:20 GMT</pubDate><ttl>60</ttl></channel></rss>